Leveragen, Inc., a Boston-based biotechnology company advancing in vivo antibody discovery, today announced the grant of ...
PhoreMost Ltd., a next-generation targeted protein degradation (TPD) company progressing a pipeline of degrader therapeutics within oncology and inflammation, today announced the publication of a ...
Why engineers are turning to system-level models. How high-fidelity digital twins help expose system-level issues. Where MBSE is experiencing the fastest adoption. The roles of AI and data science in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results